Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-220
Closed -$26.5K – 989
2026
Q1
$26.5K Buy
+220
New +$25.4K ﹤0.01% 1029
2025
Q4
– Sell
-4,094
Closed -$384K – 900
2025
Q3
$344K Sell
4,094
-5,018
-55% -$413K ﹤0.01% 502
2025
Q2
$721K Buy
9,112
+5,331
+141% +$424K 0.01% 193
2025
Q1
$339K Buy
3,781
+3,040
+410% +$284K ﹤0.01% 359
2024
Q4
$73.7K Sell
741
-873
-54% -$90K ﹤0.01% 348
2024
Q3
$183K Buy
1,614
+1,161
+256% +$138K ﹤0.01% 392
2024
Q2
$56.1K Buy
+453
New +$58.4K ﹤0.01% 420
2023
Q4
– Sell
-3,630
Closed -$374K – 476
2023
Q3
$374K Buy
+3,630
New +$391K 0.01% 419
2023
Q2
– Sell
-2,415
Closed -$257K – 658
2023
Q1
$257K Sell
2,415
-10,330
-81% -$1.12M ﹤0.01% 562
2022
Q4
$1.41M Buy
+12,745
New +$1.3M 0.02% 360
2021
Q4
– Sell
-9,400
Closed -$749K – 572
2021
Q3
$706K Sell
9,400
-312
-3% -$23.7K 0.01% 569
2021
Q2
$755K Buy
9,712
+857
+10% +$63.7K 0.01% 401
2021
Q1
$651K Buy
8,855
+7,367
+495% +$543K 0.01% 374
2020
Q4
$116K Buy
+1,488
New +$114K 0.01% 268

Other funds holding MRK

Capula Management's MRK Position: Q2 2026 in Review

Capula Management sold out of Merck (MRK) in Q2 2026, closing a stake of 220 shares — an estimated $26.5K sold.

Capula Management first reported a position in MRK in Q4 2020 and held it in 14 quarters. The position peaked at $1.41M in Q4 2022. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capula Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 220 Merck shares in Q2 2026, an estimated $26.5K.
  • Capula Management first reported a position in Merck in Q4 2020 and held it in 14 quarters.
  • Capula Management's Merck position peaked at $1.41M in Q4 2022.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.